We have located links that may give you full text access.
Basal ganglia and Parkinson's disease: neurobiological and pharmacological aspects in animals and man.
In this article, the neuroanatomy, neurochemistry and neurobiology of the nigrostriatal and mesolimbic circuitries of animals and man will be reviewed in order to gain insight into the pathognomy and etiology of cognitive and motor disorders in patients with Parkinson's disease, to increase insight into the mechanism of action of present-day antiparkinson agents, and to open perspectives for the design and development of new antiparkinson agents on a rational basis.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app